K2 HealthVentures
Overview
K2 HealthVentures is an alternative investment firm focused on providing flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries . The firm provides venture debt and equity capital to private and public life science & healthcare companies . The investment team comprises collaborative, experienced professionals with diverse backgrounds in finance and operations, as well as deep domain knowledge across various healthcare sectors . K2HV is driven by dual goals of Profit and Purpose—aiming to fuel the growth of innovative companies that will ultimately improve the lives of patients and giving a percentage of investment profits back to underserved areas in healthcare .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| NewSpring | Feb 2026 | Early Funding | Co-investor |
| Zarminali Pediatrics | Jan 2026 | Series A | Co-investor |
| Apella Technology | Jan 2026 | Series B | Co-investor |
| Phil | Jul 2025 | Debt | Lead |
| PHILHSC | Jul 2025 | Debt | Lead |
Key People
Derek Abel
Principal
Ken Tang
Principal
Nandan Munshi
Principal
Matthew C.
Healthcare And Life Sciences Investor At K2 HealthVentures
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.